| Take heed to this text |
Velys Backbone: A comprehensive system for planning and instrumenting spinal fusion procedures, streamlining the process from pre-op to post-op. | Credit score: J&J/DePuy Synthes
Johnson & Johnson’s DePuy Synthes this week launched a dual-use robotics and standalone navigation platform that makes use of its Velys robotic in backbone surgical procedure. This marks the newest growth for Velys, J&J’s robotic orthopedic surgical procedure system that gained its first FDA clearance for whole knee surgical procedure in 2021. Velys obtained FDA clearance in June for its unicompartmental knee arthroplasty.
The med-tech giant’s orthopedics division collaborated with eCential Robotics to develop the innovative Velys system, a cutting-edge surgical procedure for the spine. The eCential Health company recently obtained FDA 510(k) clearance for its cutting-edge platform last month. The businesses developed the Velys Lively Robotic-Assisted System, a cutting-edge technology specifically designed to streamline and optimize spinal fusion procedure planning and instrumentation through the Velys Backbone. The three major regions of the spine are the cervical, thoracolumbar, and sacroiliac areas.
Focusing on the business’s purpose, its experts provide specialized support to surgeons in overcoming their most complex and pressing surgical challenges. The twin-use system offers a self-contained navigation capability, further enabled by its adaptable robotics platform, allowing for greater versatility in both approach and planning. Revolutionary robotic systems enable surgeons to personalize their technique with precision-guided control, tailored to each individual’s unique style and preference.
.
The corporation highlighted the pioneering features and functionalities of Lively Robotics, which may well establish a groundbreaking standard in spinal surgery.
Velys Backbone offers customizable expertise with pathology-specific workflows, enhanced by options including Velys adaptive monitoring expertise and Velys trajectory assistance. The acquisition integrates the new product line into the DePuy Synthes core backbone portfolio of offerings, as mentioned.
DePuy Synthes, the world’s largest orthopaedic systems company, expects to achieve full industrial readiness by mid-2025.
“We’re pioneering the next generation of orthopaedic advancements through an unwavering commitment to harnessing cutting-edge digital technologies and pushing the boundaries of expertise in implantable joint replacement and navigation,” said DePuy Synthes chair Aldo Denti. “Our unwavering commitment to patient-centered care propels us forward through groundbreaking advancements in spinal surgery.”
“It’s a crucial step in elevating our Velyx Portfolio, demonstrating our commitment to empowering backbone surgeons and their patients with cutting-edge tools.”
Meanwhile, Stryker, buoyed by the significant success of its Mako robotic surgical procedures, is poised to release its Mako Shoulder product by year-end 2024.
